JP2001095563A5 - - Google Patents

Download PDF

Info

Publication number
JP2001095563A5
JP2001095563A5 JP2000236804A JP2000236804A JP2001095563A5 JP 2001095563 A5 JP2001095563 A5 JP 2001095563A5 JP 2000236804 A JP2000236804 A JP 2000236804A JP 2000236804 A JP2000236804 A JP 2000236804A JP 2001095563 A5 JP2001095563 A5 JP 2001095563A5
Authority
JP
Japan
Prior art keywords
protein
proenzyme
protease
blood coagulation
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000236804A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001095563A (ja
Filing date
Publication date
Priority claimed from DE19937219A external-priority patent/DE19937219A1/de
Application filed filed Critical
Publication of JP2001095563A publication Critical patent/JP2001095563A/ja
Publication of JP2001095563A5 publication Critical patent/JP2001095563A5/ja
Pending legal-status Critical Current

Links

JP2000236804A 1999-08-06 2000-08-04 イオン交換クロマトグラフィーによって血液凝固第ｖｉｉ因子を活性化するプロテアーゼ、そのプロ酵素または両タンパク質の混合物を純粋形態で調製する方法 Pending JP2001095563A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19937219:5 1999-08-06
DE19937219A DE19937219A1 (de) 1999-08-06 1999-08-06 Verfahren zur Reindarstellung der den Blutgerinnungsfaktor VII aktivierenden Protease, ihres Proenzyms oder eines Gemisches beider Proteine mittels Ionenaustauscherchromatographie

Publications (2)

Publication Number Publication Date
JP2001095563A JP2001095563A (ja) 2001-04-10
JP2001095563A5 true JP2001095563A5 (https=) 2007-06-07

Family

ID=7917489

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000236804A Pending JP2001095563A (ja) 1999-08-06 2000-08-04 イオン交換クロマトグラフィーによって血液凝固第ｖｉｉ因子を活性化するプロテアーゼ、そのプロ酵素または両タンパク質の混合物を純粋形態で調製する方法

Country Status (8)

Country Link
US (2) US6677440B1 (https=)
EP (1) EP1074616B1 (https=)
JP (1) JP2001095563A (https=)
KR (1) KR20010049988A (https=)
AT (1) ATE386798T1 (https=)
CA (1) CA2315306A1 (https=)
DE (2) DE19937219A1 (https=)
ES (1) ES2298110T3 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19903693A1 (de) * 1998-04-24 1999-10-28 Centeon Pharma Gmbh Protease zur Aktivierung des Gerinnungsfaktors VII
DE10023923A1 (de) * 1999-06-10 2000-12-14 Aventis Behring Gmbh Verfahren zur Bestimmung der Aktivität der Faktor VII-aktivierenden Protease aus Proteinlösungen
ES2257361T3 (es) 2000-07-26 2006-08-01 Zlb Behring Gmbh Mutantes de la proteasa activadora del factor vii y procedimiento de deteccion con anticuerpos especificos.
US7153679B2 (en) 2000-07-26 2006-12-26 Aventis Behring Gmbh Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis
JP4005338B2 (ja) * 2000-11-29 2007-11-07 ペンタックス株式会社 抗体固相化担体、および、その製造方法
US20020114800A1 (en) 2000-11-29 2002-08-22 Asahi Kogaku Kogyo Kabushiki Kaisha Carrier having immobilized antigens or antibodies and method of manufacturing thereof
DE10148037A1 (de) * 2001-09-28 2003-04-17 Aventis Behring Gmbh Verwendung der den Blutgerinnungsfaktor VII aktivierenden Protease zur Prophylaxe und Therapie von vaso-proliferativen Erkrankungen
DE10205520A1 (de) 2002-02-08 2003-08-14 Aventis Behring Gmbh Inhibitorischer, monoklonaler Antikörper gegen die den Blutgerinnungsfaktor VII aktivierende Protease
AU2003232315A1 (en) * 2002-05-07 2003-11-11 Medical Research Council Sarcosyl buffer and its use for the purification of prion protein
KR100508606B1 (ko) * 2002-11-15 2005-08-17 주식회사 바이오세움 효소 안정화 조성물 및 상기 조성물을 이용한 효소 보관방법
CN101818137A (zh) * 2003-03-18 2010-09-01 诺和诺德医疗保健公司 生产含有gla残基的丝氨酸蛋白酶的方法
CN101511387A (zh) * 2006-09-08 2009-08-19 惠氏公司 使用亲和色谱法纯化蛋白质的精氨酸洗涤液
EP2094247B1 (en) * 2006-10-20 2022-06-29 Amgen Inc. Stable polypeptide formulations
CA2683443A1 (en) 2007-04-13 2008-10-23 Catalyst Biosciences, Inc. Modified factor vii polypeptides and uses thereof
JP5119545B2 (ja) * 2007-06-19 2013-01-16 国立大学法人 筑波大学 蛋白質を含む液状組成物中における蛋白質の安定化方法
TWI465247B (zh) * 2008-04-11 2014-12-21 Catalyst Biosciences Inc 經修飾的因子ｖｉｉ多肽和其用途
SG191186A1 (en) 2010-12-15 2013-07-31 Baxter Int Eluate collection using conductivity gradient
CN103764827B (zh) * 2011-07-04 2018-04-24 恰根有限公司 可用于分离和／或纯化核酸的试剂
GB2504499A (en) * 2012-07-31 2014-02-05 Baxter Healthcare Sa Selective measurement of active human protease coagulation factors
WO2015120056A1 (en) 2014-02-04 2015-08-13 Biogen Ma Inc. Use of cation-exchange chromatography in the flow-through mode to enrich post-translational modifications
EP3833381B1 (en) 2019-08-15 2022-08-03 Catalyst Biosciences, Inc. Modified factor vii polypeptides for subcutaneous administration

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL87276A (en) * 1987-08-03 1995-07-31 Fujisawa Pharmaceutical Co Analog of tissue plasminogen activator comprising only the kringle 2 and protease domain dna encoding the same processes for the preparation thereof and pharmaceutical compositions containing the same
DE19903693A1 (de) * 1998-04-24 1999-10-28 Centeon Pharma Gmbh Protease zur Aktivierung des Gerinnungsfaktors VII
DE19937218A1 (de) * 1999-08-06 2001-02-08 Aventis Behring Gmbh Verfahren zur Reindarstellung der den Blutgerinnungsfaktor VII aktivierenden Protease, ihres Proenzyms oder eines Gemisches beider Proteine mittels Affinitätschromatographie

Similar Documents

Publication Publication Date Title
JP2001095563A5 (https=)
US6670455B1 (en) Process for the preparation in pure form of the protease activating blood clotting VII, its proenzyme or a mixture of both proteins by means of affinity chromatography
US4245051A (en) Human serum plasminogen activator
US5336610A (en) Method for purification of the zymogen of protein C or the heavy chain thereof using monoclonal antibody HPC-4
FI97298B (fi) Menetelmä kudosfaktorin inhibiittorin eristämiseksi
US4849403A (en) Protein C activator, methods of preparation and use thereof
US6677440B1 (en) Process for the preparation in pure form of the protease activating blood clotting factor VII, its proenzyme or a mixture of both proteins by means of ion-exchange chromatography
CA2006684C (en) Monoclonal antibody against protein c
BG60916B1 (bg) Химопапаин и метод за пречистването му
EP0162078A4 (en) Method for isolating a protein from a mixture containing said protein and a conformation specific antibody useful therein.
FI107166B (fi) Menetelmä entsyymien ottamiseksi talteen proentsyymeistä
DK175514B1 (da) Fremgangsmåde til oprensning af K-vitaminafhængige blodkoagulationsfaktorer
EP0139447B1 (en) A process for preparing urokinase zymogen
Poulsen et al. Purification of hog renin by affinity chromatography using the synthetic competitive inhibitor [D-Leu6] octapeptide
US5807982A (en) Affinity purified heparin
Bläckberg et al. Tissue kallikrein in severe acute pancreatitis in patients treated with high-dose intraperitoneal aprotinin
WO1986000910A1 (en) Immunopurification process
CA1170183A (en) Blood coagulation promoting product
CN100384471C (zh) 白蛋白溶液及其制备方法
Habal et al. Kininogens of human plasma
CA2031210A1 (en) Modification of plasminogen activators
AU781741B2 (en) Process for the preparation in pure form of the protease activating blood clotting factor VII, its proenzyme or mixture of both proteins by means of ion-exchange chromatography
US4780209A (en) Process for concentrating and separating trypsin inhibitor and kallidinogenase in human urine
DE3782274T2 (de) Selektiver immunoassay fuer pro-urokinase und urokinase.
EP0247258B1 (en) Process for concentrating and separating trypsin inhibitor and kallidinogenase in human urine